MDD(Mild Cognitive Impairment Delirium Dementia) Cohort

Sponsor
Keimyung University Dongsan Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05113446
Collaborator
(none)
163
2
54
81.5
1.5

Study Details

Study Description

Brief Summary

  • Identify the degree of delirium in subjects with mild cognitive impairment and find the risk factors of delirium. Mortality, hospital stay, and medical expenses are analyzed as clinical consequences related to delirium incidence.

  • Dementia conversion rate and conversion period of subjects with mild cognitive impairment with delirium and it identifies the effect of delirium on dementia conversion.

  • Develop an AI(Artificial intelligence) algorithm for predicting dementia transition in subjects with mild cognitive impairment based on the research results of the 1st, 2nd, and 3rd years.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Delirium assessment using S-CAM

Study Design

Study Type:
Observational
Anticipated Enrollment :
163 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Prospective, Longitudinal Cohort Study of the Incidence of Dementia After the Onset of Delirium in Patients With Mild Cognitive Impairment: MDD Cohort (Mild Cognitive Impairment Delirium Dementia)
Actual Study Start Date :
Jul 1, 2021
Anticipated Primary Completion Date :
Oct 31, 2022
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
MCI(Mild Cognitive Impairment) group

Inclusion criteria : Patients 65 years of age or older who are admitted to a LTC(long-term care) facilities, Patients diagnosed with mild cognitive impairment by doctors, Patients with a score of 18 or more and 23 or less on the Mini-Mental State Examination Exclusion criteria : Patients unable to measure the delirium assessment tool, The Short Confusion Assessment Methods (S-CAM) (Inouye, 2014) due to severe vision and hearing problems, Patients with serious psychiatric or neurological diagnosis,Patients who died or were transferred on the day of admission, Patients receiving emergency treatment at the time of the delirium assessment or unable to measure or intervene with S-CAM due to hospital circumstances

Diagnostic Test: Delirium assessment using S-CAM
Twice a day, the rounds of nurses in shifts, 8:00 am - 10:00 am, 4:00 pm - 6:00 pm Trained research assistants assessed delirium using S-CAM

Outcome Measures

Primary Outcome Measures

  1. Delirium incidence in participants with mild cognitive impairment [The number of subjects evaluated as positive in the delirium assessment using S-CAM for 30 days from the 1st day of study participation is statistically calculated.]

    descriptive statistics

  2. Dementia conversion rate and transition period in participants with mild cognitive impairment [The participant's dementia conversion is checked in units of 1 month, and the period until conversion to dementia is analyzed in units of 12 months for 36 months.]

    descriptive statistics

Secondary Outcome Measures

  1. Risk factors affecting participants' delirium [On the first day of data collection, the characteristics of subjects are collected through medical records. After 12 months, the risk factors affecting the occurrence of delirium among the characteristics of the subject are analyzed.]

    Logistic Regression

  2. Mortality [It is statistically calculated in 30-day, 60-day, 12-month, 24-month, and 36-month increments.]

    Kaplan-Meier survival, Cox proportional hazard regression, Logistic Regression

  3. hospital length of stay [The period from hospitalization to discharge is calculated in days and analyzed in units of 12 months.]

    Linear Regression

  4. healthcare costs [From the healthcare costs consumed during the hospital length of stay, the direct healthcare costs used only for treatment are calculated in won units and analyzed in units of 12 months.]

    Linear Regression

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients 65 years of age or older who are admitted to a LTC

  • Patients diagnosed with mild cognitive impairment by doctors

  • Patients with a score of 18 or more and 23 or less on the Mini-Mental State Examination

Exclusion Criteria:
  • Patients unable to measure the delirium assessment tool, The Short Confusion Assessment Methods (S-CAM) (Inouye, 2014) due to severe vision and hearing problems

  • Patients with serious psychiatric or neurological diagnosis,Patients who expire or were transferred on the day of admission -

  • Patients receiving emergency treatment at the time of the delirium assessment or unable to measure or intervene with S-CAM due to hospital circumstances

Contacts and Locations

Locations

Site City State Country Postal Code
1 Yangsan Seoul long-term care (LTC) facilities Daegu Gyeongsangnam-do, Korea, Republic of 50572
2 Gunsan Chamsarang long-term care (LTC) facilities Daegu Jeollabuk-do Korea, Republic of 54078

Sponsors and Collaborators

  • Keimyung University Dongsan Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kyoung ja Moon, Assistant Professor, Keimyung University Dongsan Medical Center
ClinicalTrials.gov Identifier:
NCT05113446
Other Study ID Numbers:
  • 2019R1I1A3A0106056112
First Posted:
Nov 9, 2021
Last Update Posted:
Aug 1, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kyoung ja Moon, Assistant Professor, Keimyung University Dongsan Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 1, 2022